97 related articles for article (PubMed ID: 2179961)
1. Alterations in the methylation status of ras oncogenes in B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Prog Clin Biol Res; 1990; 331():335-43. PubMed ID: 2179961
[No Abstract] [Full Text] [Related]
2. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
[TBL] [Abstract][Full Text] [Related]
3. Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver.
Vorce RL; Goodman JI
J Toxicol Environ Health; 1991 Nov; 34(3):385-95. PubMed ID: 1942124
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
J Toxicol Environ Health; 1991 Nov; 34(3):367-84. PubMed ID: 1658350
[TBL] [Abstract][Full Text] [Related]
5. Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver.
Vorce RL; Goodman JI
Mol Toxicol; 1989; 2(3):187-97. PubMed ID: 2487756
[TBL] [Abstract][Full Text] [Related]
6. Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Toxicol Appl Pharmacol; 1989 Sep; 100(3):398-410. PubMed ID: 2551075
[TBL] [Abstract][Full Text] [Related]
7. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effect of tumor promoter treatments on DNA methylation status and gene expression in B6C3F1 and C57BL/6 mouse liver and in B6C3F1 mouse liver tumors.
Counts JL; McClain RM; Goodman JI
Mol Carcinog; 1997 Feb; 18(2):97-106. PubMed ID: 9049185
[TBL] [Abstract][Full Text] [Related]
9. Oncogene-induced liver neoplasia in transgenic mice.
Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL
Oncogene; 1989 Jun; 4(6):715-24. PubMed ID: 2543942
[TBL] [Abstract][Full Text] [Related]
10. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.
Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL; Rapp UR; Kaestner K; Schwarz M
Hepatology; 1998 Apr; 27(4):1081-8. PubMed ID: 9537449
[TBL] [Abstract][Full Text] [Related]
11. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors.
Ray JS; Harbison ML; McClain RM; Goodman JI
Mol Carcinog; 1994 Mar; 9(3):155-66. PubMed ID: 7908202
[TBL] [Abstract][Full Text] [Related]
13. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion.
Counts JL; Goodman JI
Prog Clin Biol Res; 1995; 391():81-101. PubMed ID: 8532739
[TBL] [Abstract][Full Text] [Related]
15. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
16. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
17. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
Liu P; Zhao Z; Dominique B
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene activation in multistage murine hepatocarcinogenesis.
Pitot HC
Prog Clin Biol Res; 1990; 331():311-24. PubMed ID: 2179960
[No Abstract] [Full Text] [Related]
19. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
Taparowsky EJ; Heaney ML; Parsons JT
Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
Zhuang S; Söderkvist P
Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
